Kerydin
- Product NDC
- 10337-905
- 11-digit product format
- 103370905
- Labeler code
- 10337
- Product ID
- 10337-905_3d362b47-37c4-489d-91c6-a2b7ec99e207
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tavaborole
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Labeler
- PharmaDerm, A division of Fougera Pharmaceuticals Inc.
- Application
- NDA204427
- Marketing category
- NDA
- Marketing start
- 2014-07-07
- Marketing end
- 0000-00-00
- Substance
- TAVABOROLE
- Active strength
- 44 mg/mL
- Pharmacologic classes
- Oxaborole Antifungal [EPC],Protein Synthesis Inhibitors [MoA],Boron Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10337-905-10 | 10337090510 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (10337-905-10) > 10 mL in 1 BOTTLE, WITH APPLICATOR | 2014-07-07 | 0000-00-00 | No | No | Current |
| 10337-905-44 | 10337090544 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (10337-905-44) > 4 mL in 1 BOTTLE, WITH APPLICATOR | 2014-07-07 | 0000-00-00 | No | No | Current |